ClinicalTrials.Veeva

Menu

Systematic Screening for COPD in Tabacology Consultation (DEBOTA)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Smoking Cessation

Study type

Observational

Funder types

Other

Identifiers

NCT04843605
29BRC21.0036

Details and patient eligibility

About

COPD is a very common disease, an estimated 3 million people are affected in France. Unfortunately, this pathology is under-diagnosed. Several reasons can be mentioned: the banality of the symptoms or the several comorbidities.

Screening faces a major difficulty: the realization of a spirometry. Various studies have shown the complexity of the implementation of mass screening in cities by mini-spirometry.

The COPD World Health Days allow this mass screening but without visibility on the actual entry into a care pathway.

The objective of this study is to assess the impact of systematic screening for COPD during a tabacology consultation

Enrollment

112 patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects over 45 years old, followed in Tabacology unit at CHRU of BREST - No COPD patient or COPD patients not followed for more than 3 years (considered out of care)
  • No opposition filed

Exclusion criteria

  • Patients already followed for COPD
  • Contraindication to spirometry
  • Refusal to participate

Trial contacts and locations

1

Loading...

Central trial contact

Marc Beaumont; Marianne Nicol

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems